Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation

被引:23
|
作者
Welsh, Robert C. [1 ]
Cockfield, Sandra M. [1 ]
Campbell, Patrica [1 ]
Hervas-Malo, Marilou [1 ]
Gyenes, Gabor [1 ]
Dzavik, Vladamir [2 ]
机构
[1] Univ Alberta, Dept Med, Edmonton, AB, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
关键词
Cardiac risk assessment; Renal transplantation; Imaging; CHRONIC KIDNEY-DISEASE; CORONARY-ANGIOGRAPHY; CANDIDATES; MORTALITY; SURGERY;
D O I
10.1097/TP.0b013e3181ff4f61
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated. Methods. A consecutive cohort of DM/RI patients being assessed for renal transplantation was studied. We analyzed the ability of clinical characteristics and noninvasive investigation to predict significant coronary artery disease (CAD) and incidence of major adverse CV events. Results. Baseline characteristics (n = 280) are as follows: mean age 48.6 years (+/- 11.5 standard deviation), 66% men, diabetes duration 22.6 years (mean +/- 8.9 standard deviation), 92% hypertension, 46% hypercholesterolemia, 24% family history CAD, and 21% known CAD. Abnormal myocardial perfusion imaging was found in 27.8%, and 56.5% had CAD more than or equal to 50%. Although positive myocardial perfusion imaging was the only independent predictor of CAD (odds ratio 7.18, 95% confidence interval 2.98-17.3), a poor negative predicted value was observed with normal imaging in 50.3% of patients having CAD more than or equal to 50%, 35.4% CAD more than 70%, and 41.8% Duke angiographic score more than or equal to 4. At mean follow up of 4 years (median 3.9), 76 of 280 patients suffered major adverse cardiovascular events including 17% mortality. Angiographic evidence of CAD (>= 70% odds ratio 1.81, 95% confidence interval 1.02-3.23) was the only independent predictor of major adverse cardiac events. Conclusion. DM/RI patients being assessed for renal transplantation have frequent CV risk factors, high likelihood of CAD, and a 28% incidence of major adverse cardiac events after 4 years. Myocardial perfusion imagining is of little clinical utility as a screening tool for CAD in this population. Only angiographic CAD was predictive of subsequent major adverse cardiac events. Further studies of risk stratification and revascularization in this high-risk population are warranted.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 50 条
  • [31] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [32] The Cardiovascular Burden in End-Stage Renal Disease
    Cozzolino, Mario
    Galassi, Andrea
    Pivari, Francesca
    Ciceri, Paola
    Conte, Ferruccio
    [J]. EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 : 44 - 57
  • [33] Cardiovascular calcification in end-stage renal disease
    Salusky, IB
    Goodman, WG
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (02) : 336 - 339
  • [34] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [35] Hyperleptinaemia of end-stage renal disease is corrected by renal transplantation
    Landt, N
    Brennan, DC
    Parvin, CA
    Flavin, KS
    Dagogo-Jack, S
    Coyne, DW
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (09) : 2271 - 2275
  • [36] Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
    Lonning, Kjersti
    Midtvedt, Karsten
    Leivestad, Torbjorn
    Reisaeter, Anna V.
    Line, Pal-Dag
    Hartmann, Anders
    Heldal, Kristian
    [J]. TRANSPLANTATION, 2016, 100 (12) : 2705 - 2709
  • [37] RENAL-TRANSPLANTATION IN END-STAGE DIABETIC NEPHROPATHY
    IZENSTEIN, B
    LIBERTINO, J
    TAKACS, F
    DELIA, J
    GOLDSTEIN, HH
    [J]. DIABETES, 1976, 25 : 367 - 367
  • [38] Predicting cardiovascular events in patients with end-stage renal disease on the waiting list for renal transplantation - to invade or not to invade?
    De Lima, J. J. G.
    Paula, F. J.
    Martinez Filho, E.
    Meneghetti, C.
    Cesar, L. A. M.
    Ramires, J. A. F.
    Krieger, E. M.
    Gowdak, L. H. W.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 10 - 10
  • [39] Cardiac disease in diabetic end-stage renal disease
    R. N. Foley
    B. F. Culleton
    P. S. Parfrey
    J. D. Harriett
    G. M. Kent
    D. C. Murray
    Paul E. Barre
    [J]. Diabetologia, 1997, 40 : 1307 - 1312
  • [40] Cardiac disease in diabetic end-stage renal disease
    Foley, RN
    Culleton, BF
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Murray, DC
    Barre, PE
    [J]. DIABETOLOGIA, 1997, 40 (11) : 1307 - 1312